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Introduction
Pregnancy and postpartum are particular vulnerable periods where the onset or exacerbation of depressive episodes is common and affects approximately 8% of Canadian women. 1 While the hypothalamus-pituitaryadrenal (HPA) axis has long been associated with the neurobiology of major depressive disorder (MDD), the role of the HPA axis in perinatal depression is less known. 2 Individuals with unipolar depression exhibit flattened diurnal cortisol rhythms and have a lower peak of awakening cortisol. 3 It has been postulated that an augmented positive feedback loop leading to higher levels of cortisol and to placental corticotropin-releasing hormone (pCRH) during pregnancy and a longer HPA refractory period in postpartum may be associated with increased risk for postpartum depression (PPD). 2 Salivary cortisol (sCORT) awakening response in the 3rd trimester of pregnancy has been shown to negatively predict HPA stress responses in postpartum. 4 Alpha-amylase is an enzyme that has been shown to be a marker of sympathetic nervous system activity as levels increase in humans in response to stressors. 5 Inducing psychosocial stress in early 2nd and 3rd
trimester pregnant women resulted in attenuation of alpha-amylase in the stress response compared to nonpregnant women and prolonged cortisol recovery in early 2nd trimester pregnant women compared to early 3rd trimester pregnant and non-pregnant women. 6 Many risk factors for PPD have been identified, including poor marital and social support, life stressors, low self-esteem, pessimism about pregnancy, and antenatal depression and anxiety. [7] [8] [9] However, no biological markers have been clearly established in the genesis of this disorder.
This longitudinal study is a follow-up to a recent cross-sectional study where we found that euthymic women with a history of MDD had worse recognition memory than women without a lifetime history of MDD for negative, but not positive images, an effect that was independent of sCORT and salivary alpha-amylase (sAA) during incidental encoding. 10 Given that previous studies have shown that elevated levels of sCORT and sAA during incidental encoding is associated with better memory for emotional content, 11 and individuals currently depressed recall more negative compared to positive content, 12 our results suggested that clinical remission may be associated with an opposite cognitive processing of negative emotional information.
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Objectives and hypotheses
The main objectives of this study were to investigate: confirmed a past diagnosis of MDD in participants with a history of MDD. All women with a history of MDD were euthymic for at least 3 months prior to study entry.
Measures
Severity of depressive symptoms were assessed using the EPDS, 14 anxiety symptoms using the StateTrait Anxiety Index (STAI), 15 and sleep quality using the Pittsburgh Sleep Quality Index (PSQI). 16 Incidental encoding and recognition memory tasks including positive, neutral, and negative images selected from the International Affective Picture System (IAPS) and sorbettes used to collect the salivary hormone samples are previously described. 10 Collection time of samples was based on the participants' schedule and occurred between 10:00 and 19:00 hrs.
Procedure
The Salimetrics® Cortisol and α-Amylase Kinetic enzyme assay kits procedure instructions for quantifying sCORT and sAA, respectively, are described in detail elsewhere. 17, 18 sCORT and sAA samples were 
Data analysis
Statistical analyses were performed using the It is important to note that these results were positive in the whole sample. sCORT means for the high-and low-risk groups immediately after the task images. Three (7.3%) women met diagnostic criteria for MDD in postpartum, two of whom had a previous history of MDD, a result that is consistent with the 8% prevalence of PPD previously reported in the Canadian population.
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Discussion
We found that higher levels of sCORT immediately after an incidental encoding memory task during pregnancy were associated with lower EPDS scores in postpartum across participant groups. A recent study found a positive association between EPDS scores (≥10) and sCORT levels at 6 weeks postpartum, but no significant correlation between sCORT levels at 36
weeks of gestation and EPDS scores in late pregnancy and postpartum. 19 In addition, another study found that higher levels of pCRH during mid-pregnancy were associated with depressive symptoms at 3-months postpartum. 20 Together, these studies support the hypothesis that changes in certain HPA markers (sCORT and pCRH) may be associated with increased depressive symptoms in the postpartum period. However, contrary to our hypothesis, we did not find an association between emotional memory during pregnancy and postpartum depressive symptoms.
A healthy pregnancy is characterized by increased levels of hormones, including sCORT, from early to late pregnancy, which typically normalize within 2 weeks postpartum. 21 sCORT levels that do not normalize within this time may be linked to an increased risk for PPD. 21 Postpartum EPDS scores were not predicted by the cortisol or the alpha-amylase AUC G . Differences in sCORT levels exist between depressed postpartum women and currently euthymic postpartum women within 30 minutes of awakening, but not at 3 and 12 hours after awakening. 22 The fact that the samples were collected between 10:00 and 19:00 hrs during pregnancy (i.e., after 30 minutes of awakening) may be one of the reasons why cortisol AUC G did not predict changes in EPDS scores postpartum.
The exact etiology of PPD remains unclear. PPD is currently classified in the DSM-5 under the MDD umbrella with a specifier "with peripartum onset." were recruited from a Community Midwives clinic, which is less biased than results from samples originated from women treated in tertiary care centers.
